Dare Bioscience, Inc. (DARE)

NASDAQ: DARE · IEX Real-Time Price · USD
1.24
0.00 (0.00%)
At close: Jul 6, 2022 4:00 PM
1.27
+0.03 (2.42%)
After-hours: Jul 6, 2022 7:44 PM EDT

Income Statement (Trailing)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ending 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Revenue
00000000000000000000000000000.030.080.090.090.050.01---0.63
Revenue Growth (YoY)
-----------------------------37.74%1233.33%----99.04%----
Gross Profit
00000000000000000000000000000.030.080.090.090.050.01---0.63
Selling, General & Admin
8.988.357.736.876.636.556.136.15.855.274.924.784.634.664.614.493.812.71.770.723.020.168.7711.7211.6611.2210.9610.459.768.597.566.345.76.17---6.39
Research & Development
30.6930.6230.1425.9124.1220.7716.512.279.238.557.847.327.026.415.424.262.040.980.310.037.550.0724.4531.5430.725.9523.4919.3315.311.778.517.177.729.7---15.81
Other Operating Expenses
0.10.10.10.10.10.080.180.290.430.530.680.550.645.8113.0313.0312.787.490.150.150.150.40000000000000000
Operating Expenses
39.7839.0737.9732.8830.8427.422.8218.6615.5214.3413.4412.6512.2916.8823.0621.7718.6311.182.230.910.720.6333.2243.2642.3637.1734.4529.7725.0620.3616.0713.5113.4215.87---22.2
Operating Income
-39.78-39.07-37.97-32.88-30.84-27.4-22.82-18.66-15.52-14.34-13.44-12.65-12.29-16.88-23.06-21.77-18.63-11.18-2.23-0.9-10.72-0.63-33.22-43.26-42.36-37.17-34.45-29.77-25.02-20.28-15.98-13.42-13.37-15.86----21.58
Interest Expense / Income
0000000000000000000.010.020.620.041.962.462.372.431.911.591.341.081.351.541.61.49---0.57
Other Expense / Income
-0-0.37-0.37-0.37-0.37-00-0.02-0.05-0.08-0.13-0.15-0.16-0.14-0.110.230.30.320.330.03-0.020-0.05-0.06-0.02-0.01-0-02.491.982.032.03-0.48-0.2000-0.04
Pretax Income
-39.77-38.7-37.6-32.51-30.47-27.4-22.83-18.64-15.46-14.26-13.31-12.5-12.13-16.74-22.95-22.01-18.92-11.5-2.57-0.96-11.32-0.67-35.13-45.66-44.71-39.59-36.35-31.36-28.86-23.34-19.36-17-14.49-17.14000-22.1
Net Income
-39.77-38.7-37.6-32.51-30.47-27.4-22.83-18.64-15.46-14.26-13.31-12.5-12.13-16.74-22.95-22.01-18.92-11.5-2.57-0.96-11.32-0.67-35.13-45.66-44.71-39.59-36.35-31.36-28.86-23.34-19.36-17-14.49-17.14----22.1
Preferred Dividends
0000.010.010.010.0100.790.790.790.790000000000000000000000---0.07
Net Income Common
-39.77-38.7-37.6-32.52-30.48-27.41-22.83-18.64-16.25-15.05-14.1-13.28-12.13-16.74-22.95-22.01-18.92-11.5-2.57-0.96-11.32-0.67-35.13-45.66-44.71-39.59-36.35-31.36-28.86-23.34-19.36-17-14.49-17.14----22.17
Shares Outstanding (Basic)
846171504530322724161716111111119351111333332122000000
Shares Outstanding (Diluted)
84617150453032272416171611111111935111133333212200---0
Shares Change
88.63%103.23%124.06%88.83%86.99%93.16%89.34%65.85%108.36%45.16%46.06%41.00%31.52%232.04%129.07%1155.18%854.35%287.10%500.38%-66.75%-66.74%-67.17%-69.59%2.52%34.46%74.80%35.69%58.09%2485.87%2025.95%---12.31%----
EPS (Basic)
-0.64-0.63-0.74-0.80-0.89-0.91-0.90-0.86-0.88-0.97-1.01-1.04-1.07-1.57-3.95-4.05-4.28-3.56-1.38-1.07-4.49-0.81-12.79-16.67-16.40-15.60-15.10-14.00-14.70-16.00-85.10-126.30-201.50-250.50----363.90
EPS (Diluted)
-0.64-0.63-0.74-0.80-0.89-0.91-0.90-0.86-0.88-0.97-1.01-1.04-1.07-1.57-3.95-4.05-4.28-3.56-1.38-1.07-4.49-0.81-12.79-16.67-16.40-15.60-15.10-14.00-14.70-16.00-85.10-126.30-201.50-250.50----363.90
Free Cash Flow Per Share
-0.39-0.47-0.40-0.69-0.61-0.84-0.63-0.66-0.70-0.85-0.73-0.73-1.00-0.96-0.75-0.63-0.70-0.79-0.6525.2114.50-0.45-10.40-15.09-13.82-12.65-10.83-10.19-11.57-13.23-8.35-8.52-199.33-242.88----347.67
Gross Margin
----------------------------100.00%100.00%100.00%100.00%100.00%100.00%---100.00%
Operating Margin
-----------------------------75827.27%-25348.75%-18581.40%-15609.30%-25220.76%-200.00%----3452.00%
Profit Margin
-----------------------------87442.42%-29177.50%-22505.81%-19761.63%-27330.19%-200.00%----3547.84%
Free Cash Flow Margin
-----------------------------71351.51%-24057.50%-19534.88%-16727.91%-29598.11%-200.00%----3389.60%
EBITDA
-39.83-38.77-37.68-32.6-30.57-27.52-22.92-18.72-15.53-14.28-13.32-12.48-12.11-16.73-22.95-22.01-18.92-11.5-2.56-1.06-10.76-0.63-33.1-42.97-42.12-36.97-34.29-29.63-27.38-22.13-17.88-15.32-12.73-15.46----21.19
EBITDA Margin
-----------------------------82975.76%-27666.25%-20788.37%-17812.79%-24015.09%-200.00%----3390.08%
Depreciation & Amortization
-0.06-0.07-0.08-0.09-0.09-0.12-0.09-0.09-0.06-0.02-0.010.010.010.0100000-0.13-0.0600.060.240.210.190.160.150.130.130.130.140.160.2---0.35
EBIT
-39.77-38.7-37.6-32.51-30.47-27.4-22.83-18.64-15.46-14.26-13.31-12.5-12.13-16.74-22.95-22.01-18.92-11.5-2.56-0.94-10.7-0.63-33.17-43.2-42.33-37.16-34.45-29.77-27.51-22.26-18.01-15.46-12.89-15.66----21.53
EBIT Margin
-----------------------------83372.73%-27823.75%-20936.05%-17974.42%-24320.76%-200.00%----3445.44%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).